Freshfields Bruckhaus Deringer advised Apera and the super senior banks on the financing of pharmaceutical company Euro Vital Pharma Group. Taylor Wessing has advised the borrower. PRK Partners reportedly advised the lenders on the deal.
The transaction included term loans, various current accounts, and special loans. The pan-European debt fund Apera, together with Deutsche Bank and Hamburger Sparkasse provided the financing.
According to Taylor Wessing, the financing has been tailored to support EVP’s further growth plans as well as the refinancing of recent acquisitions in Spain, the UK, and Slovakia. The funding will be used, among others, for the acquisition of the Spain-based Korott Group, operating in the same industry.
EVP is a private label over-the-counter healthcare provider, offering a range of products and featuring its own research, development, and distribution capabilities.
The Taylor Wessing team was led by Germany-based Partner Ulf Gosejacob and included Partners Michael Stein, Michael Beyer, and Christopher Peine, and Senior Associate Kian Boehmer, UK-based Partner Martin Yells, Senior Associates Katie Horbury and Kate Bowden, and Associate Jessica Richards-Webb, Slovakia-based Partners Silvia Hlavackova and Juraj Frindrich, and Senior Associate Jana Brezinova, as well as Spain-based Partners Hector Bross and Kai Christian Fischer.
The Freshfields team was led by Germany-based Partner Michael Josenhans and included Partner Mario Huther, Counsel Nina Heym, Principal Associate Vanessa Steiner, Associates Laura Korndorfer and Matthis Grenzer, Austria-based Lawyer Anouschka Zagorski, UK-based Partner Mandeep Lotay, as well as Spain-based Partner Ana Lopez, and Associates Victoria Bobo and Arturo Dauffi.
